Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

The 2026 Cancer in Iowa Report, published by the Iowa Cancer Registry, is highlighting insights into cancer trends among Iowa's farming community as well as children and young adults in ...

The 2026 European Association of Urology (EAU) annual meeting featured an advancement in metastatic castration resistant ...

Drinking tea never goes out of style, and for good reason. The soothing beverage isn’t just valued across cultures; tea has a slew of health-boosting qualities. In my experience as a dietitian, I’ve ...

A new clinical study published in the scientific journal The New England Journal of Medicine suggests that an experimental treatment can significantly reduce epileptic seizures in children with Dravet ...

This week's biotech landscape witnessed key FDA approvals, EU approvals, IND clearances, acquisitions, and clinical trial data readouts across key therapeutic areas such ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

The 2026 European Association of Urology (EAU) annual meeting featured an advancements in diagnosis and prognosis, and personalized treatment for renal cell carcinoma (RCC) session and a presentation ...

(“Clywedog”) to create a differentiated company focusing on clinical metabolic and autoimmune pipeline assets and to build on the Company’s base of high caliber institutional investors, expected to ...